These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 27786042)

  • 21. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.
    Jo S; Fonseca TL; Bocco BMLC; Fernandes GW; McAninch EA; Bolin AP; Da Conceição RR; Werneck-de-Castro JP; Ignacio DL; Egri P; Németh D; Fekete C; Bernardi MM; Leitch VD; Mannan NS; Curry KF; Butterfield NC; Bassett JHD; Williams GR; Gereben B; Ribeiro MO; Bianco AC
    J Clin Invest; 2019 Jan; 129(1):230-245. PubMed ID: 30352046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Thyroid Function Variations Within the Laboratory Reference Range on Health Status, Mood, and Cognition in Levothyroxine-Treated Subjects.
    Samuels MH; Kolobova I; Smeraglio A; Niederhausen M; Janowsky JS; Schuff KG
    Thyroid; 2016 Sep; 26(9):1173-84. PubMed ID: 27338133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Thyroid-Hormone Requirements Consistent With Type 3 Deiodinase Induction Related to Ibrutinib in a Thyroidectomized Woman.
    Mazori AY; Skamagas M
    AACE Clin Case Rep; 2021; 7(2):121-123. PubMed ID: 34095468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2-Thr92Ala, thyroid hormone levels and biochemical hypothyroidism in preeclampsia.
    Procopciuc LM; Caracostea G; Hazi G; Nemeti G; Stamatian F
    Gynecol Endocrinol; 2017 Feb; 33(2):136-140. PubMed ID: 27809617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study.
    Vigário Pdos S; Vaisman F; Coeli CM; Ward L; Graf H; Carvalho G; Júnior RM; Vaisman M
    Endocrine; 2013 Oct; 44(2):434-40. PubMed ID: 23371817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.
    Klaver EI; van Loon HC; Stienstra R; Links TP; Keers JC; Kema IP; Kobold AC; van der Klauw MM; Wolffenbuttel BH
    Thyroid; 2013 Sep; 23(9):1066-73. PubMed ID: 23530992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Arici M; Oztas E; Yanar F; Aksakal N; Ozcinar B; Ozhan G
    Endocr J; 2018 Mar; 65(3):317-323. PubMed ID: 29321381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density.
    Heemstra KA; Hoftijzer H; van der Deure WM; Peeters RP; Hamdy NA; Pereira A; Corssmit EP; Romijn JA; Visser TJ; Smit JW
    J Bone Miner Res; 2010 Jun; 25(6):1385-91. PubMed ID: 20200941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy.
    Appelhof BC; Peeters RP; Wiersinga WM; Visser TJ; Wekking EM; Huyser J; Schene AH; Tijssen JG; Hoogendijk WJ; Fliers E
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6296-9. PubMed ID: 16144953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P; Siddique H; Simmons DJ; Greenwood R; Dayan CM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):261-7. PubMed ID: 17479444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liothyronine use in primary hypothyroidism - current concepts.
    Concepción-Zavaleta MJ; Ildefonso-Najarro SP; Paz-Ibarra JL; Valdivia Fernández-Dávila FR; Deutz Gómez-Condori DC; Rivera-Fabián KE; Herrera-Cabezas RG; Concepción-Urteaga LA
    Endokrynol Pol; 2021; 72(6):650-660. PubMed ID: 34855197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy.
    Baran J; Isaza A; Bojarsky M; Alzoebie L; Song M; Halada S; Sisko L; Gonzales S; Mostoufi-Moab S; Bauer AJ
    Front Endocrinol (Lausanne); 2024; 15():1443394. PubMed ID: 39205688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
    Hennessey JV
    Endocr Pract; 2023 Jul; 29(7):572-580. PubMed ID: 37419564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism.
    Shakir MKM; Brooks DI; McAninch EA; Fonseca TL; Mai VQ; Bianco AC; Hoang TD
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4400-e4413. PubMed ID: 34185829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of DIO2 and MCT10 Polymorphisms With Persistent Symptoms in LT4-Treated Patients in the UK Biobank.
    Jensen CZ; Isaksen JL; Ahlberg G; Olesen MS; Nygaard B; Ellervik C; Kanters JK
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e613-e622. PubMed ID: 37740545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement.
    Djurovic M; Pereira AM; Smit JWA; Vasovic O; Damjanovic S; Jemuovic Z; Pavlovic D; Miljic D; Pekic S; Stojanovic M; Asanin M; Krljanac G; Petakov M
    Endocrine; 2018 Oct; 62(1):136-143. PubMed ID: 29959689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement.
    Saravanan P; Visser TJ; Dayan CM
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3389-93. PubMed ID: 16804044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increases in thyrotropin within the near-normal range are associated with increased triiodothyronine but not increased thyroxine in the pediatric age group.
    Karavani G; Strich D; Edri S; Gillis D
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1471-5. PubMed ID: 24878053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.